🇺🇸 FDA
Pipeline program

Cilostazol

2025CYFYIRB-BA-113

Approved small_molecule active

Quick answer

Cilostazol for Cerebral Small Vessel Disease is a Approved program (small_molecule) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).

Program details

Company
The First People's Hospital of Lianyungang
Indication
Cerebral Small Vessel Disease
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials